{ "items": [ "\n\n
\n \n 25 March 2022\n \n
\n\n \n\n \n\n \n \n \n \n Major Funding Awards\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \nThe \u00a33.9M Wellcome Collaborative Award will be used to identify the drivers of pain in people living with rheumatoid arthritis.
\n \n\n\n \n 7 March 2022\n \n
\n\n \n\n \n\n \n \n \n \n Research Highlights\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers from the University of Oxford have used data from UK Biobank participants to look at changes to the brain on average 4.5 months after mild SARS-CoV-2 infection.
\n \n\n\n \n 7 March 2022\n \n
\n\n \n\n \n\n \n \n \n \n Major Funding Awards\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Oxford Health Clinical Research Facility (OH CRF) is one of 28 facilities across England to benefit from nearly \u00a3161 million that has been awarded by the National Institute for Health Research (NIHR) to expand early phase clinical research delivery in NHS hospitals.
\n \n\n\n \n 15 February 2022\n \n
\n\n \n\n \n\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Keith Channon has been appointed as the next Head of the Radcliffe Department of Medicine (RDM).
\n \n\n\n \n 10 January 2022\n \n
\n\n \n\n \n\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \nMatthew Rushworth replaces Kia Nobre as interim Head of the Department of Experimental Psychology
\n \n\n\n \n 7 January 2022\n \n
\n\n \n\n \n\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \nHuman-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.
\n \n\n\n \n 19 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n Major Funding Awards\n \n \n \n \n Research Highlights\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 3 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 3 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n Research Highlights\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \nMembers of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.
\n \n\n\n \n 1 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \nThe recent launch event of the Experimental Medicine Industry Partnership was an exciting collaboration between industry representatives and researchers from the University of Oxford. During the event, a series of workshops were held to discuss opportunities, challenges, and future directions for the application of experimental medicine in psychiatric drug development.
\n \n\n\n \n 27 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n Major Funding Awards\n \n \n \n \n Research Highlights\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \nThe University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.
\n \n\n\n \n 27 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n Major Funding Awards\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \nA major new $9 million project funded by the Aligning Science Across Parkinson\u2019s (ASAP) initiative will map the original circuits vulnerable to Parkinson\u2019s on an unprecedented scale. The project is a collaboration between a core team of Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institute, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.
\n \n\n\n \n 25 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n Major Funding Awards\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) \u2013 a brainstem nucleus \u2013 in human consciousness.
\n \n\n\n \n 10 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Department of Experimental Psychology has recruited two senior researchers.
\n \n\n\n \n 16 August 2021\n \n
\n\n \n\n \n\n \n \n \n \n Awards and Honours\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Large Lecture Theatre in the Sherrington Building is being renamed the Blakemore Lecture Theatre in tribute to the longest serving Waynflete Professor of Physiology Sir Colin Blakemore FRS following a prestigious Festschrift event held in Professor Blakemore's honour.
\n \n\n\n \n 5 August 2021\n \n
\n\n \n\n \n\n \n \n \n \n Research Highlights\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \nMore research is needed to improve the treatment of brain diseases such as depression, Alzheimer\u2019s or ADHD. A widely held view within the scientific community is that this cannot be done without ethically conducted animal research.
\n \n\n\n \n 24 June 2021\n \n
\n\n \n\n \n\n \n \n \n \n Major Funding Awards\n \n \n \n \n Research Highlights\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \nAn Oxford project using artificial intelligence to develop digital triage tools for mental health clinicians (CHRONOS) is one of 38 projects support by the second wave of the NHS AI Lab's AI in Health and Care Award.
\n \n\n\n \n 11 June 2021\n \n
\n\n \n\n \n\n \n \n \n \n Research Highlights\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Belinda Lennox has been welcomed to the role of Head of the Department of Psychiatry at the University of Oxford and will take over leadership in October 2021.
\n \n\n\n \n 23 April 2021\n \n
\n\n \n\n \n\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \nThe new partnership between Oxford Health NHS Foundation Trust, the University of Oxford, the University of Toronto, and the Centre for Addiction and Mental Health (CAMH) in Toronto, will enable the development of key structures to facilitate collaboration.
\n \n\n\n \n 26 March 2021\n \n
\n\n \n\n \n\n \n \n \n \n Strategic Developments\n \n \n\n \n\n\n
\n \n\n \n \n \nGround-breaking multi-disciplinary research is to be launched today by the University of Oxford into the impact of poverty and social inequalities in early childhood, thanks to major funding from the Leverhulme Trust.
\n \n\n